Salidroside directly activates HSC70, revealing a new role for HSC70 in BDNF signalling and neurogenesis after cerebral ischemia
Published: 26 May 2023| Version 1 | DOI: 10.17632/3732f4z4jf.1
Contributors:
Lai Wenfang, Rui Luo, Yuheng Tang, Zhengshuang Yu, Binbin Zhou, Zelin Yang, John Brown, Guizhu HongDescription
Background: Ischemic stroke still has few effective therapies and novel neuroprotective agents are attracting great interest. One of these, salidroside, a principal bioactive component of Rhodiola crenulata, extracts of which are used to treat stroke, exhibits neuroprotective properties across a remarkably wide time window in experimental stroke models. Purpose: To explore whether salidroside induces neurogenesis after cerebral ischemia and to identify its primary molecular target.
Files
Institutions
- Fujian University of Traditional Chinese Medicine
Categories
Stem Cell
Funders
- the Natural Science Foundation of Fujian Province, ChinaGrant ID: 82174001
- the Natural Science Foundation of Fujian Province, ChinaGrant ID: 81973503
- the Natural Science Foundation of Fujian Province, ChinaGrant ID: 2021J02014
- the Natural Science Foundation of Fujian Province, ChinaGrant ID: 2020J01727
- the Natural Science Foundation of Fujian Province, ChinaGrant ID: 2019J01345